Alexion Pharmaceuticals Inc said on Friday its board of directors had unanimously rejected hedge fund Elliott Management’s push for a “proactive sale” process of the entire company because it would not be in the best interest of shareholders.
Alexion Pharmaceuticals Inc said on Friday its board of directors had unanimously rejected hedge fund Elliott Management’s push for a “proactive sale” process of the entire company because it would not be in the best interest of shareholders.